CymitQuimica logo

CAS 1391052-18-8

:

Rasagiline 13C3 Mesylate (Racemic)

Description:
Rasagiline 13C3 Mesylate (Racemic) is a chemical compound primarily used in the treatment of Parkinson's disease. It is a selective, irreversible inhibitor of monoamine oxidase B (MAO-B), which plays a crucial role in the metabolism of neurotransmitters such as dopamine. By inhibiting this enzyme, Rasagiline helps to increase dopamine levels in the brain, thereby alleviating symptoms associated with Parkinson's disease. The "13C3" designation indicates that the compound contains three carbon-13 isotopes, which can be useful in research and metabolic studies. The mesylate salt form enhances the compound's solubility and stability, making it suitable for pharmaceutical formulations. As a racemic mixture, it contains equal amounts of both enantiomers, which may exhibit different pharmacological properties. The compound is typically administered orally and is known for its favorable side effect profile compared to other treatments. Overall, Rasagiline 13C3 Mesylate (Racemic) represents an important therapeutic option in managing Parkinson's disease symptoms and improving patients' quality of life.
Formula:C13H17NO3S
Synonyms:
  • Rasagiline mesylate 13C3Q: What is
  • Rasagiline mesylate 13C3 Q: What are the applications of
  • Rasagiline mesylate 13C3 Q: What is the storage condition of
  • Rasagiline mesylate 13C3
  • Rasagiline mesylate 13C3 Q: What is the CAS Number of
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
  • Rasagiline-13C3 Mesylate

    CAS:
    Formula:C913C3H13N·CH4O3S
    Color and Shape:White To Off-White Solid
    Molecular weight:174.22 96.10

    Ref: 4Z-R-191

    5mg
    To inquire
    100mg
    To inquire
    10mg
    1,942.00€
    25mg
    3,580.00€
    50mg
    5,764.00€
  • Rasagiline-13C3 Mesylate

    Controlled Product
    CAS:

    Applications Labelled Rasagiline. A selective irreversible MAO-B inhibitor. Rasagiline is an Antiparkinsonian agent.
    References Rabey, J.M. et al.: Clin. Neuropharmacol., 23, 324 (2000); Glezer, S. et al.: Eur. J. Pharmacol., 472, 173 (2003); Youdim, M.B.H. et al.: Biochem. Pharmacol., 66, 1635 (2003); Chen, J.J. et al.: J. Clin. Pharmacol., 45, 878 (2005);

    Formula:C3C9H13N·CH4O3S
    Color and Shape:Neat
    Molecular weight:270.32

    Ref: TR-R126003

    1mg
    371.00€
    10mg
    2,588.00€
  • Rasagiline 13C3 mesylate (racemic)

    CAS:

    Rasagiline is a research tool that belongs to the class of ligands. It has been shown to activate receptors, such as ion channels and cell biology. Rasagiline has been shown to inhibit ion channels in the brain and thereby reduce the effects of Parkinson's disease. Rasagiline has also been used as an inhibitor for high purity peptides, proteins and antibodies.

    Formula:C13H17NO3S
    Purity:Min. 95%
    Molecular weight:270.32 g/mol

    Ref: 3D-RFC05218

    1mg
    Discontinued
    5mg
    Discontinued
    10mg
    Discontinued
    25mg
    Discontinued
    50mg
    Discontinued
    Discontinued product